PHARMING GROUP N.V. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.879 EUR | -1.79% |
|
+0.29% | -14.74% |
| May. 08 | Pharming Group N.V. Provides Revenue Guidance for 2024 | CI |
| May. 08 | Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechSijmen de Vries (Executives)Good evening or good afternoon, ladies and gentle...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The Group is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development.
Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.
Sector
Pharmaceuticals
Calendar
2024-05-21
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.879
EUR
Average target price
2
EUR
Spread / Average Target
+127.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -14.74% | 650M | |
| +32.95% | 700B | |
| +26.51% | 569B | |
| -4.97% | 358B | |
| +18.83% | 330B | |
| +3.54% | 287B | |
| +15.70% | 236B | |
| +6.68% | 202B | |
| -9.08% | 197B | |
| +6.70% | 161B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Transcript : Pharming Group N.V., 2021 Earnings Call, Mar 24, 2022